• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.85% Nasdaq Down 1.02%

    Cytokinetics, Incorporated (CYTK)

    -NasdaqCM
    6.10 Down 0.12(1.93%) 10:29AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:6.22
    Open:6.16
    Bid:6.07 x 100
    Ask:6.09 x 100
    1y Target Est:13.80
    Beta:1.53
    Earnings Date:Jul 28 - Aug 3 (Est.)
    Day's Range:6.06 - 6.18
    52wk Range:3.05 - 8.61
    Volume:36,712
    Avg Vol (3m):377,297
    Market Cap:236.17M
    P/E (ttm):N/A
    EPS (ttm):-0.40
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    CYTKDown 1.93%236.17M
    BIIBDown 1.19%92.67B
    LGNDDown 0.77%1.74B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):5.55
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.14
    Quarterly EPS Est (Jun-15) :-0.24
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):-0.37

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Cytokinetics, Incorporated, a clinical stage biopharmaceutical company, focuses on the discovery and development of novel small molecule therapeutics that modulate muscle function for the treatment of serious diseases and medical conditions. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback